CX3CR1+T Cell Predict Immunotherapy Efficacy

Clinical trial NCT06054152 · COMPLETED

Trial details

NCT number: NCT06054152
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2023-04-10
Primary completion: 2025-01-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.